If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on RBS's remaining State Aid obligation

26 Jul 2017 16:31

RNS Number : 1995M
Royal Bank of Scotland Group PLC
26 July 2017
 

 

The Royal Bank of Scotland Group plc

 

Update on RBS's remaining State Aid obligation regarding the business previously described as Williams & Glyn

 

26 July 2017

 

 

Following the consultation process carried out by the European Commission ("EC") and a market testing exercise carried out by HM Treasury ("HMT"), RBS has been informed by HMT that an alternative remedies package has now been agreed in principle between HMT and the EC Commissioner responsible for competition.

 

 

This revised package is focused on the following two remedies to promote competition in the market for banking services to small and medium enterprises ("SMEs") in the UK.

 

· A £425m Capability and Innovation Fund, to be administered by an independent body, that will grant funding to a range of competitors in the UK banking and financial technology sectors; and

· An Incentivised Switching Scheme which will provide £275m of funding for eligible challenger banks to help them incentivise SME customers of the business previously described as Williams & Glyn to switch their accounts and loans from RBS paid in the form of "dowries" to the receiving bank. An additional £75m will be made available by RBS to cover customers' costs of switching.

 

This revised package will be submitted to the EC's College of Commissioners for approval and if agreed will form the basis of a new term sheet in relation to RBS's remaining State Aid commitments. It is expected to come into effect during H2 2017, upon which RBS will no longer be obliged to achieve separation and divestment of the business previously described as Williams & Glyn by 31 December 2017.

 

A £750m provision was recognised in RBS's 2016 Annual Results in relation to the previously proposed package of measures. An incremental charge of £50m in relation to the revised package and its implementation costs will be recorded in the RBS H1 2017 results which will be announced 4th August 2017, taking the total provision to £800m.

 

RBS will incur running costs for the duration of the scheme, which are estimated at around £35m and will be substantially incurred before the end of 2019. Furthermore, under the terms of the revised package, should the uptake within the Incentivised Switching Scheme not be sufficient, RBS could be required to make a further contribution, capped at £50m.

 

Ross McEwan, RBS CEO, said "We welcome the progress that HMT and the EC Commissioner responsible for competition have made on agreeing an alternative package of remedies to increase competition in the SME marketplace. We await a formal decision on this proposal which would allow us to resolve our final State Aid divestment obligation."

 

 

Investor Relations

+44 (0) 20 7672 1758

 

RBS Media Relations

+44 (0) 131 523 4205

 

 

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to RBS and its subsidiaries' regulatory capital position, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBS's future economic results, business and capital plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK annual report and accounts and interim reports and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

MAR

 

This announcement contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR). For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Matt Waymark, Head of Investor Relations for The Royal Bank of Scotland Group.

 

 

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFVEDIIRFID
Date   Source Headline
22nd Jul 20202:00 pmRNSChange of Name
16th Jul 20207:00 amRNSIntention to Change Name on 22 July 2020
1st Jul 202012:29 pmRNSDirector/PDMR Shareholding
30th Jun 20204:26 pmRNSTotal Voting Rights
29th Jun 20207:00 amRNSNotice of Redemption
25th Jun 20209:19 amRNSRBSG pricing of US$1.5bn Additional Tier 1 Notes
23rd Jun 20207:00 amRNSChanges to the Alternative Remedies Package
11th Jun 20205:31 pmRNSPublication of Supplementary Prospectus
11th Jun 20208:00 amRNSRBS and NatWest Markets announce appointments
8th Jun 20204:15 pmRNSHolding(s) in Company
8th Jun 20203:38 pmRNSTotal Voting Rights and Capital
8th Jun 20203:20 pmRNSDirector/PDMR Shareholding
29th May 20203:09 pmRNSDirector/PDMR Shareholding
29th May 20202:25 pmRNSTotal Voting Rights
29th May 202012:52 pmRNSDividend Declaration
21st May 202010:15 amRNSAdditional Listing
20th May 20207:04 amRNSRBSG pricing of US$1.6bn of Senior Notes
14th May 20201:00 pmRNSDirector/PDMR Shareholding
13th May 20204:01 pmRNSPublication of Final Terms
12th May 202011:16 amRNSQ1 2020 Pillar 3 Supplement
5th May 20204:57 pmRNSPublication of Supplementary Prospectus
1st May 20204:20 pmRNSPublication of Suppl.Prospcts
1st May 20207:00 amRNSQ1 Interim Management Statement
30th Apr 202012:20 pmRNSTotal Voting Rights
29th Apr 20204:33 pmRNSResult of AGM
29th Apr 20203:01 pmRNSAGM Statement
28th Apr 20203:51 pmRNSDirector/PDMR Shareholding
27th Apr 20204:40 pmRNSSecond Price Monitoring Extn
27th Apr 20204:35 pmRNSPrice Monitoring Extension
27th Apr 20203:58 pmRNSDisclosure of rights attached to equity shares
20th Apr 202012:38 pmRNSDividend Declaration
14th Apr 20204:21 pmRNSVirtual Shareholder Event – 29 April 2020
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
6th Apr 20202:14 pmRNSBlock Listing Six Monthly Return
3rd Apr 20204:11 pmRNSAmendment of Final Terms
3rd Apr 20203:24 pmRNSNotice of AGM
2nd Apr 202012:11 pmRNSDirector/PDMR Shareholding
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202011:34 amRNSRoyal Bank of Scotland Group
1st Apr 20207:00 amRNSResponse to Covid-19
26th Mar 20204:42 pmRNSSecond Price Monitoring Extn
26th Mar 20204:37 pmRNSPrice Monitoring Extension
25th Mar 20204:41 pmRNSSecond Price Monitoring Extn
25th Mar 20204:35 pmRNSPrice Monitoring Extension
24th Mar 20204:42 pmRNSSecond Price Monitoring Extn
24th Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:16 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.